Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy.

Carpenter LL, Bayat L, Moreno F, Kling MA, Price LH, Tyrka AR, Kinkead B, Owens MJ, Nemeroff CB.

Psychiatry Res. 2008 Jan 15;157(1-3):123-9. Epub 2007 Oct 31.

PMID:
17976740
2.

Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression.

Geracioti TD Jr, Carpenter LL, Owens MJ, Baker DG, Ekhator NN, Horn PS, Strawn JR, Sanacora G, Kinkead B, Price LH, Nemeroff CB.

Am J Psychiatry. 2006 Apr;163(4):637-43.

PMID:
16585438
3.

Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.

Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH.

Biol Psychiatry. 2004 Sep 15;56(6):418-26.

PMID:
15364040
4.

Substance P in serum and cerebrospinal fluid of depressed patients: no effect of antidepressant treatment.

Deuschle M, Sander P, Herpfer I, Fiebich BL, Heuser I, Lieb K.

Psychiatry Res. 2005 Jul 15;136(1):1-6.

PMID:
16024091
5.

Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes.

Nahas Z, Marangell LB, Husain MM, Rush AJ, Sackeim HA, Lisanby SH, Martinez JM, George MS.

J Clin Psychiatry. 2005 Sep;66(9):1097-104.

PMID:
16187765
7.

Vagus nerve stimulation for depression: efficacy and safety in a European study.

Schlaepfer TE, Frick C, Zobel A, Maier W, Heuser I, Bajbouj M, O'Keane V, Corcoran C, Adolfsson R, Trimble M, Rau H, Hoff HJ, Padberg F, Müller-Siecheneder F, Audenaert K, Van den Abbeele D, Stanga Z, Hasdemir M.

Psychol Med. 2008 May;38(5):651-61. doi: 10.1017/S0033291707001924. Epub 2008 Jan 4. Erratum in: Psychol Med. 2008 Jul;38(7):1067. Matthews, K [removed]; Christmas, D [removed].

PMID:
18177525
8.

Vagus nerve stimulation (VNS) for depression: what do we know now and what should be done next?

Nahas Z, Burns C, Foust MJ, Short B, Herbsman T, George MS.

Curr Psychiatry Rep. 2006 Dec;8(6):445-51. Review.

PMID:
17094924
9.

A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.

George MS, Rush AJ, Marangell LB, Sackeim HA, Brannan SK, Davis SM, Howland R, Kling MA, Moreno F, Rittberg B, Dunner D, Schwartz T, Carpenter L, Burke M, Ninan P, Goodnick P.

Biol Psychiatry. 2005 Sep 1;58(5):364-73.

PMID:
16139582
10.

Clinical issues in considering vagus nerve stimulation for treatment-resistant depression.

Rush AJ, Siefert SE.

Exp Neurol. 2009 Sep;219(1):36-43. doi: 10.1016/j.expneurol.2009.04.015. Epub 2009 May 3. Review.

PMID:
19397908
11.

Vagus nerve stimulation for depression: rationale, anatomical and physiological basis of efficacy and future prospects.

Park MC, Goldman MA, Carpenter LL, Price LH, Friehs GM.

Acta Neurochir Suppl. 2007;97(Pt 2):407-16. Review.

PMID:
17691329
12.

Vagus nerve stimulation and deep brain stimulation for treatment resistant depression.

Carpenter LL, Friehs GM, Tyrka AR, Rasmussen S, Price LH, Greenberg BD.

Med Health R I. 2006 Apr;89(4):137, 140-1. Review.

PMID:
16676910
13.

Cervical vagus nerve stimulation for treatment-resistant depression.

Carpenter LL, Friehs GM, Price LH.

Neurosurg Clin N Am. 2003 Apr;14(2):275-82. Review.

PMID:
12856494
14.
15.

P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder.

Neuhaus AH, Luborzewski A, Rentzsch J, Brakemeier EL, Opgen-Rhein C, Gallinat J, Bajbouj M.

J Affect Disord. 2007 Jun;100(1-3):123-8. Epub 2006 Nov 13.

PMID:
17098290
16.

Brain-derived neurotrophic factor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation.

Lang UE, Bajbouj M, Gallinat J, Hellweg R.

Psychopharmacology (Berl). 2006 Jul;187(1):56-9. Epub 2006 Apr 22.

PMID:
16767416
17.

Treatment-resistant depression: new therapies on the horizon.

Trivedi MH.

Ann Clin Psychiatry. 2003 Mar;15(1):59-70. Review.

PMID:
12839433
18.

Combined VNS-rTMS treatment in a patient with therapy resistant depression.

Sperling W, Kornhuber J, Wiltfang J, Bleich S.

Pharmacopsychiatry. 2007 Jan;40(1):39-40. No abstract available.

PMID:
17327961
19.

The effects of vagus nerve stimulation on sleep EEG in depression: a preliminary report.

Armitage R, Husain M, Hoffmann R, Rush AJ.

J Psychosom Res. 2003 May;54(5):475-82.

PMID:
12726905
20.

Vagus nerve stimulation acutely alters food craving in adults with depression.

Bodenlos JS, Kose S, Borckardt JJ, Nahas Z, Shaw D, O'Neil PM, George MS.

Appetite. 2007 Mar;48(2):145-53. Epub 2006 Oct 31.

PMID:
17081655

Supplemental Content

Support Center